v3.20.1
Condensed Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 4,951,631 $ 6,777,052
Prepaid research and development 743,194 536,916
Prepaid expenses and other current assets 240,382 359,499
Total Current Assets 5,935,207 7,673,467
Intangible assets, net 6,029 6,170
Total Other Assets 6,029 6,170
Total Assets 5,941,236 7,679,637
Current Liabilities:    
Accounts payable 196,382 190,204
Accrued expenses 193,447 348,847
Total Current Liabilities 389,829 539,051
Commitments and contingencies
Shareholders' Equity    
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at March 31, 2020 and December 31, 2019
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 10,629,603 and 10,368,352 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 10,629 10,368
Additional paid in capital 28,444,390 27,757,017
Accumulated deficit (22,903,612) (20,626,799)
Total Shareholders' Equity 5,551,407 7,140,586
Total Liabilities and Shareholders' Equity $ 5,941,236 $ 7,679,637

Source